Inhalt

P.J. Barnes: Glucocorticoids and Asthma; H.-D. Volk: Immunomonitoring of GC Therapy; W.Sterry and K. Asadullah: Topical GC Therapy in Dermatology;H.K. Väänänen and P.L. Härkönen: Bone Effects of GC Therapy; U.Pleyer and Z. Sherif: Corticosteroids in Ophtalmology; U.Wahn: Special Problems in GC Treatment of Children; D.D. DeFranco: Functional Implications of GC Receptor Trafficking;G.L.Hager: The Dynamics of Intranuclear Movement of Chromatin Remodeling by the GC Receptor; C. Caelles et al.: GC Receptor Anatgonism of AP-1 Activity by Inhibition of MAPK Family; O. Kassel and A.C.B. Cato: Mast Cells as Targets for GC in the Treatment of Allergic Disorders;A.-C. Wikström et al.: Cytosolic GC Receptor Interacting Proteins; M.J.M. Schaaf and J.A. Cidlowski: The GC Receptor ß-isoform: A Perspective on its Relevance in Human Health and Disease; B. Groner and C. Shemanko:. Cooperation of Nuclear Transcription Factors Regulated by Steroid and Peptide Hormones; W. Vanden Berghe et al.: Induction and Repression of NF-kB-driven Inflammatory Genes; A. Dostert and T. Heinzel: DNA-dependent Cofactor Selectivity of the GC Receptor; P. Herrlich: Cofactor Requirement for Transcriptional Crosstalk between the GC Receptor and Other Transcription Factors; C.Kellendonk et al.; X Analysis of GC Receptor Function by Gene Targeting Analysis in the Mouse; P. Mittelstadt et al.: Glucocorticoid-inducible Genes that Regulate T-Cell Function; U. Egner: Structural Analysis of the GR Ligand-binding Domain; H. Schäcke et al.: Selective GC Receptor Agonists (SEGRAs): A Novel Class of Antiinflammatory Compounds;